Historically, COVID-19 symptoms have been fevers or chills, cough, shortness of breath, cough, congestion or a runny nose, sore throat, loss of taste or smell, fatigue and body aches, headache, nausea ...

The chronic illnesses that make doctors doubt their patients often start after what “should” be a short-lived sickness—like ...

Care for the flu is generally supportive — meaning rest, hydration, and over-the-counter medication, but as the Mayo Clinic ...

Most U.S. states are reporting high or very high flu-like activity, while COVID-19 rates remain lower than this time last ...

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Illinois, Indiana, Michigan, Minnesota, Ohio and Wisconsin had the highest rates, with 9.2 percent of tests coming back positive.

Paxlovid vs placebo reduced COVID-19-related hospitalization and death due to any cause through 28 days, as well as the duration of COVID-19 symptoms.

Researchers have provided the molecular explanation for why some osteoporosis drugs offer protection against COVID-19.

Patients who revisit the emergency department shortly after discharge are at high risk for complications and death, exacerbated by COVID-19 screening workload. Detection efforts impact outcomes.

Patients who received the original monovalent mRNA COVID-19 vaccine were less likely than unvaccinated patients to be hospitalized for COVID-19-associated VTE.

In New York, the vaccination rate among people 65 and older for surveys taken between Oct. 27 and Nov. 30 was 36.8%, up from ...

The latest confirmed hospitalization data shows notable increases of more than 30% in hospital admissions due to both ...